Valuation: genOway

Market Cap 22.77M 25.89M 21.16M 19.46M 36.49M 2.51B 37.15M 253M 98.68M 1.22B 97.21M 95.11M 4.24B P/E 2024 *
-
P/E 2025 -
Enterprise Value 29.49M 33.53M 27.4M 25.2M 47.26M 3.25B 48.1M 328M 128M 1.58B 126M 123M 5.5B EV / Sales 2024
1.28x
EV / Sales 2025 1.11x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.20%
1 week-5.36%
Current month+4.22%
1 month+2.92%
3 months-1.20%
6 months-5.00%
Current year-8.86%
1 week 2.47
Extreme 2.47
2.57
1 month 2.21
Extreme 2.21
2.63
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.2
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 1999-02-28
Director of Finance/CFO - 2015-09-30
Director TitleAgeSince
Director/Board Member - 1999-02-28
Director/Board Member - -
Director/Board Member 74 -
Date Insider Type Main position Quantity % Market Cap.
1/20/22 Buy

Chief Executive Officer

12,500 0.1376%
11/17/21 Sell

Chief Executive Officer

5,000 0.0553%
11/13/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.20%-5.36%-20.06%-35.68% 25.89M
+1.08%-5.74%-4.98%+10.45% 46.35B
+3.13%+5.34%+402.93%+605.08% 40.13B
+2.14%+2.95%+10.83%+65.45% 36.33B
+4.43%-1.51%+6.73%-9.17% 34.6B
+1.23%-2.05%+0.56%+30.76% 26.77B
+0.29%-2.75% - - 16.66B
+14.71%+12.62%+38.50%+146.99% 16.91B
-6.32%-4.86%+4.36%+8.22% 13.05B
+1.82%+0.19%+1.45%-30.74% 13.05B
Average +1.98%-0.93%+48.92%+87.93% 24.39B
Weighted average by Cap. +2.36%-1.16%+76.17%+131.33%

Financials

2024 2025
Net sales 27.53M 31.3M 25.58M 23.52M 44.11M 3.03B 44.9M 306M 119M 1.48B 118M 115M 5.13B 28.6M 32.52M 26.57M 24.44M 45.83M 3.15B 46.65M 318M 124M 1.54B 122M 119M 5.33B
Net income 1.83M 2.08M 1.7M 1.56M 2.93M 202M 2.99M 20.34M 7.93M 98.32M 7.81M 7.65M 341M 928K 1.05M 862K 793K 1.49M 102M 1.51M 10.31M 4.02M 49.83M 3.96M 3.87M 173M
Net Debt 623K 708K 579K 532K 998K 68.6M 1.02M 6.92M 2.7M 33.46M 2.66M 2.6M 116M 6.72M 7.64M 6.24M 5.74M 10.76M 740M 10.96M 74.63M 29.11M 361M 28.68M 28.06M 1.25B
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
26-07-23 €2.470 -1.20% 17,468
26-07-22 €2.500 0.00% 1,510
26-07-21 €2.500 +0.81% 3,356
26-07-20 €2.480 -3.50% 18,831
26-07-17 €2.570 -1.53% 5,141
  1. Stock Market
  2. Stocks
  3. ALGEN Stock